Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

In fact, many people experience nosebleeds as the temperature rises, and there’s more to it than meets the eye. Nosebleeds ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

A rapidly growing weed may cause hayfever sufferers to battle symptoms longer this year as it could pose a threat to ...

SoundHealth, the medical technology company behind the SONU Band, has launched the first-ever medical-grade Android app ...

Allergic rhinitis, often called hay fever, mimics cold symptoms but isn’t caused by a virus or bacteria. Non-allergic rhinitis, triggered by irritants like smoke, strong odours, or weather changes, ...

After spending a day outside during peak hay fever season, you can be “literally coated in pollen”, Dr Bull says. When you ...